Commercial
Blended and augmented: Reimagining the role of the rep
The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement
Commercial
Uncorking the compliance bottlenecks in digital
Making compliance processes fit for the digital age quickly moved from being merely an important problem to a mission critical one this...
Commercial
Blended and augmented: Reimagining the role of the rep
As pharma tentatively contemplates a post-pandemic future, it is clear that the old sales model has been swept away by this year’s...
Latest
-
-
Commercial
Uncorking the compliance bottlenecks in digital
The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology -
Clinical
Maimah Karmo: Surviving, fighting, winning
The Tigerlily Foundation President and Founder is more hopeful than ever that she can help pharma give Black women the representation they deserve in trials and beyond -
Medical
COVID-19: A data challenge and a catalyst for new insights
The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D -
Patients and Medical
Building a health equity culture
Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts
Most Popular
Andrew Stone, (Nov 24, 2020)
The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D
Andrew Stone, (Dec 17, 2020)
The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology
Andrew Stone, (Dec 18, 2020)
The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement
Opinion
Jill Donahue, (Oct 2, 2020)
Pfizer's Medical Affairs Lead, Rare Diseases, talks about purpose, patients and pharma's power to do good
Jill Donahue, (Apr 14, 2020)
Merck's Thomas D’Hooghe shares his thoughts on passion, purpose, leading people and making a difference
Commercial
-
Blended and augmented: Reimagining the role of the rep
The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement -
Uncorking the compliance bottlenecks in digital
The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology -
Creating a holistic customer experience
Finding solutions to unmet customer needs means harnessing the combined power of medical and marketing skills – and creating a culture to match -
Adapting to the multichannel imperative: A special report
Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales. -
Australia’s field force: evolving on fast forward
Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets
Access and Evidence
-
A burning desire to make a difference for patients
Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients -
From reactive to predictive: Concerto’s new compositions
Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton -
Evolving HTA frameworks to accelerate innovation
Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague -
Can we afford to pay for future cures?
Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging -
Advancing RWE together with academia
Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust
Patients and Medical
-
Building a health equity culture
Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts -
Digital companions: helping improve patient treatment journeys
The virtual health explosion isn't going away. This just at the start of an era of digital enhancement -
Racially diverse clinical trials: A new patient-led legacy takes root
Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities -
Patient engagement: Breaking through in digital
The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential -
Amplifying the patient voice in rare disease access
Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom
Latest Videos
Upcoming events
View All EventsJanuary 2021
-
Workshop: Transform your sales learning to meet new demand
Jan 27, 2021 - Jan 27, 2021
Virtual workshop
April 2021
-
Pharma Customer Engagement Europe
Apr 20, 2021 - Apr 21, 2021
Digital Conference, Networking & Exhibition
May 2021
-
Pharma USA (formerly eyeforpharma Philadelphia)
May 25, 2021 - Jun 4, 2021
Digital Conference, Networking and Exhibition
September 2021
-
Pharma Japan
Sep 7, 2021 - Sep 9, 2021
October 2021
-
Pharma Europe (formerly eyeforpharma Barcelona)
Oct 12, 2021 - Oct 22, 2021
November 2021
-
Total Health
Nov 16, 2021 - Nov 17, 2021